The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s pharmaceutical exports. The new trade agreement’s parameters could shape deals the Trump administration is pursuing with other countries.
The post Higher Drug Prices, No Tariffs: U.K. Trade Pact Shows How Trump Is Coaxing Countries to Pay More for Meds appeared first on MedCity News.
